---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-23-000097"
form_type: "8-K"
ticker: "AUPH"
cik: "0001600620"
company_name: "Aurinia Pharmaceuticals Inc."
filed_at: "2023-01-03T23:59:59+00:00"
generated_at: "2026-06-20T20:52:08.512211+00:00"
event_type: "litigation"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Aurinia settles patent dispute with Sun Pharma, ends IPR and litigation

## Summary
- Joint motion to terminate IPR on Aurinia's U.S. Patent No. 10,286,036 filed.
- Parties agree to dismiss all claims and counterclaims in patent litigation over Sun's CEQUA product.
- Settlement conditional on USPTO approval of IPR termination.
- No financial terms disclosed; both parties cease future actions.

## SEC filing metadata
- accession: 0001628280-23-000097
- form_type: 8-K
- ticker: AUPH
- cik: 0001600620
- company_name: Aurinia Pharmaceuticals Inc.
- filed_at: 2023-01-03T23:59:59+00:00
- event_type: litigation
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1600620/000162828023000097/0001628280-23-000097-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1600620/000162828023000097/auph-20230103.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-23-000097
- JSON: https://secwatch.observer/filing/0001628280-23-000097.json
- Plain text: https://secwatch.observer/filing/0001628280-23-000097.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.